Homepage / About Us / Key Historical Data / Key Historical Data

Key Historical Data

 2015:

Another good year for Chemgineering. The implementation of the strategy for 2011-2015 is successfully completed and the 2020 strategy is drawn up. The priority areas for the coming years: internationalisation and expansion of the  LSTK projects and hospital pharmacy business fields.

2014:

The growth strategy has been successfully implemented: We had the highest number of employees and the highest sales figures in the history of our company. In particular, large-scale engineering projects in Switzerland, Germany and Austria contributed to an excellent result. Overall, the order inflow was good, due in part to international projects.

2013:

Continuous streamlining oft the organization and reinforcement of the Business Units.

2012:

Chemgineering is growing and hires 45 new staff members. The company is awarded one large-scale project each in Switzerland and Austria, and opens an additional branch in Kirchbichl (Austria).

2011:

Good market development and outstanding result because of favorable economic climate and consequent implementation of the approved strategy in the whole organization.

2010:

Examination of the strategic situation: Focus on growth in the home markets and developing of possibilities in the business field “operational excellence”.

2009:

Both the Consulting and the Engineering unit feel the worldwide economical crisis with regard to earnings. However, by awarding large construction and qualification projects, clients show their confidence in Chemgineering.

2008:

Founding of Chegineering Serbien d.o.o. in Beograd. The Chemgineering Business Design (Consulting) and Chemgineering Technology (Engineering) companies operate independently.

2007:

The Chemgineering Management buys back the shares of Uhde AG.

2004:

The large-scale project MAB, Roche-Basle, is launched. Chemgineering delivers the Construction Management “Process”.

2003:

Strategic alliance with Uhde AG, a Thyssen-Krupp company. Projects and employees of the former «Uhde Pharma Consult», Heidelberg, have been integrated in Chemgineering Deutschland GmbH. The Novartis large-scale project PHAD is launched.

2001:

The Chemgineering Management buys the shares of Fluor Daniel Inc. Chemgineering is now fully in the hands of its executive committee.

2000:

The Chemgineering Group extends the executive committee to seven members, and establishes three strategic business units: Engineering, Information Systems and Consulting. Large-scale vitamin project at Roche, Grenzach, is completed successfully.

1999:

The Chemgineering management buys the shares of Bertrams. Shortly afterwards, Bertrams AG declares bankruptcy.

1998:

Fluor Daniel Inc. founds Advanced Solutions International B.V. (ASIBV), whose name was adopted from ASI GmbH. Chemgineering acquires 60% of the SCInformatik AG. The large-scale project Centeon in Marburg is successfully completed.

1997:

The office in Stuttgart opens to offer services in Computerized System Validation (CSV) and logistics. Chemgineering Planung GmbH launches its operations in Austria.

1996:

Bertrams AG (Muttenz) and Fluor Daniel Corp. (USA) found the joint venture Chemgineering.

 

Chemgineering Business Design AG | Binningerstrasse 2 | 4142 Münchenstein | T +41 61 467 89 00 | F +41 61 467 89 01 | www.chemgineering.com | info@chemgineering.com